Therapeutic options in primary open-angle glaucoma.
Wishart
P
P
Royal Liverpool Hospital, U.K.
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005902:Glaucoma, Open-Angle / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D009883:Ophthalmic Solutions; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D014130:Trabeculectomy / Q000379:methods; D016896:Treatment Outcome; D014794:Visual Fields
D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D009883:Ophthalmic Solutions; D011465:Prostaglandins, Synthetic